Since NF-κB upregulates several important antiapoptotic genes, it seems plausible that an increase in NF-κB activity after antiandrogen treatment actually provides a survival advantage to metastasizing prostate cancer cells. This evidence concerns the gene NFKB1 and Familial prostate cancer.